曲妥珠单抗联合化疗：是否有令人信服的生存获益？ - Suppr

Trastuzumab plus chemotherapy: convincing survival benefit or not?

作者信息

Vogel Charles L, Tan-Chiu Elizabeth

出版信息

J Clin Oncol. 2005 Jul 1;23(19):4247-50. doi: 10.1200/JCO.2005.12.903. Epub 2005 May 23.

DOI:10.1200/JCO.2005.12.903

PMID:15911863

Abstract

摘要

相似文献

Trastuzumab plus chemotherapy: convincing survival benefit or not?

J Clin Oncol. 2005 Jul 1;23(19):4247-50. doi: 10.1200/JCO.2005.12.903. Epub 2005 May 23.

[Trastuzumab for treatment of advanced breast cancers].

Nihon Rinsho. 2000 Apr;58 Suppl:340-4.

RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.

Clin Breast Cancer. 2008 Aug;8(4):370-3. doi: 10.3816/CBC.2008.n.045.

Trastuzumab plus chemotherapy improves survival in early-stage HER2-positive breast cancer patients.

Oncology (Williston Park). 2005 Jun;19(7):851, 862.

Ongoing and planned adjuvant trials with trastuzumab.

Semin Oncol. 2000 Dec;27(6 Suppl 11):26-32; discussion 92-100.

Herceptin: help for advanced breast cancer.

Health News. 2001 May;7(5):4.

Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint.

Breast Cancer Res Treat. 2010 Jul;122(1):9-10. doi: 10.1007/s10549-010-0919-7. Epub 2010 May 22.

Trastuzumab faces trials, clinical and otherwise.

J Natl Cancer Inst. 2006 Mar 1;98(5):296-8. doi: 10.1093/jnci/djj110.

Sequential or concurrent administration of trastuzumab in early breast cancer? Too early to judge.

J Clin Oncol. 2010 Jul 20;28(21):e353-4. doi: 10.1200/JCO.2009.27.8770. Epub 2010 Apr 20.

[Current studies reveal significant survival advantage. Breast cancer therapy with herceptin].

Krankenpfl J. 2003;41(10-12):215.

引用本文的文献

Translating cancer trial endpoints into the language of managed care.

Biotechnol Healthc. 2008 May;5(1):22-35.

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma.

J Cancer Res Clin Oncol. 2011 Sep;137(9):1317-27. doi: 10.1007/s00432-011-1000-6. Epub 2011 Jul 8.

Meta-analysis of concomitant compared to sequential adjuvant trastuzumab in breast cancer: the sooner the better.

Med Oncol. 2012 Jun;29(2):503-10. doi: 10.1007/s12032-011-9897-9. Epub 2011 Mar 13.

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Int J Clin Oncol. 2010 Dec;15(6):615-20. doi: 10.1007/s10147-010-0093-2. Epub 2010 May 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Trastuzumab plus chemotherapy: convincing survival benefit or not?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献